Top

Published in:

01-10-2021 | Foreign Body Aspiration | IM - COMMENTARY

Early antibiotic treatment in emergency department: the critical balance

Authors: Alessandro Russo, Mario Venditti, Giancarlo Ceccarelli, Claudio Maria Mastroianni, Gabriella d’Ettorre

Published in: Internal and Emergency Medicine | Issue 7/2021

Excerpt

An early administration of appropriate antibiotic therapy is universally considered the most important intervention associated with survival in hospitalized patients with suspected or confirmed infection; conversely, delayed administration of an effective antibiotic therapy is associated with high mortality rates, especially in patients with sepsis or septic shock [1]. As a matter of fact, the probability of death increases with the number of hours of delay of antibiotic administration [2]. …

Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A et al (2009) Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 180:861–866CrossRef

Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP (2014) Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42:1749–1755CrossRef

Aga M, Naganuma T, Ohashi Y, Matsuzawa H, Matsuzaka S, Cammack I, Yamada G, Serizawa Y (2021) Association of early antibiotic therapy and in-hospital mortality in adult mild-to-moderate acute aspiration pneumonitis: a cohort study. Intern Emerg Med. https://doi.org/10.1007/s11739-021-02695-y (Epub ahead of print)CrossRefPubMed

Falcone M, Bassetti M, Tiseo G, Giordano C, Nencini E, Russo A, Graziano E, Tagliaferri E, Leonildi A, Barnini S, Farcomeni A, Menichetti F (2020) Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care 24:29CrossRef

Bassetti M, Russo A, Righi E, Dolso E, Merelli M, D’Aurizio F, Sartor A, Curcio F (2020) Role of procalcitonin in predicting etiology in bacteremic patients: report from a large single-center experience. J Infect Public Health 13:40–45CrossRef

Bassetti M, Russo A, Righi E, Dolso E, Merelli M, D’Aurizio F, Sartor A, Curcio F (2019) Role of procalcitonin in bacteremic patients and its potential use in predicting infection etiology. Expert Rev Anti Infect Ther 17:99–105CrossRef

Russo A, Venditti M, Ceccarelli G, Mastroianni CM, d’Ettorre G (2021) Procalcitonin in daily clinical practice: an evergreen tool also during a pandemic. Intern Emerg Med 16(3):541–543CrossRef

Alam N, Oskam E, Stassen PM, Exter PV, van de Ven PM, Haak HR et al (2018) Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med 6:40e50CrossRef

Zhang D, Micek ST, Kollef MH (2015) Time to appropriate antibiotic therapy is an independent determinant of post-infection ICU and hospital lengths of stay in patients with sepsis. Crit Care Med 43:2133–2140CrossRef

10.

Tabak YP, Vankeepuram L, Ye G, Jeffers K, Gupta V, Murray PR (2018) Blood culture turnaround time in US acute care hospitals and implications for laboratory process optimization. J Clin Microbiol 56:e00500-18CrossRef

11.

Russo A, Falcone M, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale PL, Oliver A, Ruiz-Garbajosa P, Gasch O, Gozalo M, Pitout J, Akova M, Peña C, Cisneros JM, Hernández-Torres A, Farcomeni A, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Karaiskos I, de la Calle C, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Mora-Rillo M, Rodriguez-Gomez J, Souli M, Bonomo RA, Paterson DL, Carmeli Y, Pascual A, Rodríguez-Baño J, Venditti M, REIPI/ESGBIS/INCREMENT investigators (2018) Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae. Int J Antimicrob Agents 52:577–585CrossRef

12.

Russo A, Bassetti M, Bellelli V, Bianchi L, Marincola Cattaneo F, Mazzocchetti S, Paciacconi E, Cottini F, Schiattarella A, Tufaro G, Sabetta F, D’Avino A (2021) Efficacy of a fosfomycin-containing regimen for treatment of severe pneumonia caused by multidrug-resistant Acinetobacter baumannii: a prospective. Observational Study Infect Dis Ther 10:187–200CrossRef

13.

Russo A, Bassetti M, Ceccarelli G, Carannante N, Losito AR, Bartoletti M, Corcione S, Granata G, Santoro A, Giacobbe DR, Peghin M, Vena A, Amadori F, Segala FV, Giannella M, Di Caprio G, Menichetti F, Del Bono V, Mussini C, Petrosillo N, De Rosa FG, Viale P, Tumbarello M, Tascini C, Viscoli C, Venditti M, ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva) (2019) Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study. J Infect 79:130–138CrossRef

14.

Tumbarello M, Raffaelli F, Giannella M, Mantengoli E, Mularoni A, Venditti M, De Rosa FG, Sarmati L, Bassetti M, Brindicci G, Rossi M, Luzzati R, Grossi PA, Corona A, Capone A, Falcone M, Mussini C, Trecarichi EM, Cascio A, Guffanti E, Russo A, De Pascale G, Tascini C, Gentile I, Losito AR, Bussini L, Conti G, Ceccarelli G, Corcione S, Compagno M, Giacobbe DR, Saracino A, Fantoni M, Antinori S, Peghin M, Bonfanti P, Oliva A, De Gasperi A, Tiseo G, Rovelli C, Meschiari M, Shbaklo N, Spanu T, Cauda R, Viale P (2021) Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study. Clin Infect Dis 22:ciab176. https://doi.org/10.1093/cid/ciab176 (Epub ahead of print)CrossRef

15.

Bassetti M, Vena A, Russo A (1995) Management of patients with septic shock due to Candida infection. Hosp Pract 2018(46):258–265

16.

Russo A, Tiseo G, Falcone M, Menichetti F (2020) Pulmonary aspergillosis: an evolving challenge for diagnosis and treatment. Infect Dis Ther 9:511–524CrossRef

17.

Spagnolello O, Pierangeli A, Cedrone MC, Di Biagio V, Gentile M, Leonardi A, Valeriano C, Innocenti GP, Santinelli L, Borrazzo C, Russo A, Oliveto G, Viscido A, Ciccozzi M, Bertazzoni G, d’Ettorre G, Ceccarelli G (2021) Viral community acquired pneumonia at the emergency department: report from the pre COVID-19 age. J Med Virol. https://doi.org/10.1002/jmv.26980 (Epub ahead of print)CrossRefPubMedPubMedCentral

18.

Falcone M, Russo A, Giannella M, Cangemi R, Scarpellini MG, Bertazzoni G, Alarcón JM, Taliani G, Palange P, Farcomeni A, Vestri A, Bouza E, Violi F, Venditti M (2015) Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia. PLoS One 10:e0119528CrossRef

19.

Nauclér P, Huttner A, van Werkhoven CH, Singer M, Tattevin P, Einav S, Tängdén T (2021) Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship. Clin Microbiol Infect 27:175–181CrossRef

20.

Santarossa M, Kilber EN, Wenzler E, Albarillo FS, Sterk EJ (2019) Bundled up: a narrative review of antimicrobial stewardship initiatives and bundles in the emergency department. Pharmacy (Basel) 7(4):145CrossRef

Title: Early antibiotic treatment in emergency department: the critical balance
Authors: Alessandro Russo
Mario Venditti
Giancarlo Ceccarelli
Claudio Maria Mastroianni
Gabriella d’Ettorre
Publication date: 01-10-2021
Publisher: Springer International Publishing
Keywords: Foreign Body Aspiration
Antibiotic
Foreign Body Aspiration
Meningitis
Septic Shock
Aspiration
Published in: Internal and Emergency Medicine / Issue 7/2021
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-021-02779-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2021

Association of early antibiotic therapy and in-hospital mortality in adult mild-to-moderate acute aspiration pneumonitis: a cohort study

Jugular vein ultrasound for estimating changes in blood volume: a new tool for all physicians

The impact of an outpatient parenteral antibiotic therapy (OPAT) clinic for adults with cellulitis: an interrupted time series study

SARS-CoV-2 vs smallpox: mass vaccinations in the mirror

The clinical course of COVID-19 in systemic sclerosis patients, report from 150 patients

Hypocalcemia is associated with adverse clinical course in patients with upper gastrointestinal bleeding

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials